Statistics

Total Visits

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial66

Select a period of time:

Number of views in the range

Views
Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial42

Views

Views
January 20252
February 20255
March 202519
April 20254
May 20259
June 20252
July 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States18
Singapore16
Brazil3
Austria2
Spain1
United Kingdom1
Italy1
 

Top cities views

Views
Fort Lee3
Council Bluffs1
Florianópolis1
Itapajé1
Jaraguá do Sul1
Los Angeles1
Vienna1